Molina Healthcare (NYSE:MOH) PT Lowered to $348.00

Posted by Defense World Staff on Feb 25th, 2023

Molina Healthcare (NYSE:MOH – Get Rating) had its price objective lowered by stock analysts at JPMorgan Chase & Co. from $360.00 to $348.00 in a research report issued on Thursday, The Fly reports. The firm presently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price objective suggests a potential upside of 21.13% from the stock’s previous close.

Other equities research analysts also recently issued research reports about the stock. Barclays dropped their target price on shares of Molina Healthcare from $400.00 to $375.00 and set an “overweight” rating for the company in a research report on Wednesday, January 4th. Cowen boosted their target price on shares of Molina Healthcare from $371.00 to $380.00 in a research report on Monday, November 7th. Wells Fargo & Company dropped their target price on shares of Molina Healthcare from $340.00 to $307.00 and set an “underweight” rating for the company in a research report on Friday, February 17th. StockNews.com downgraded shares of Molina Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Wednesday. Finally, Cowen boosted their target price on shares of Molina Healthcare from $371.00 to $380.00 in a research report on Monday, November 7th. One research analyst has rated the stock with a sell rating, four have given a hold rating and five have issued a buy rating to the company’s stock. According to data from MarketBeat.com, Molina Healthcare presently has an average rating of “Hold” and an average target price of $358.64.

Molina Healthcare Stock Performance

Molina Healthcare stock opened at $287.29 on Thursday. Molina Healthcare has a 12-month low of $249.78 and a 12-month high of $374.00. The company has a market capitalization of $16.63 billion, a price-to-earnings ratio of 21.20, a price-to-earnings-growth ratio of 0.76 and a beta of 0.69. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.47 and a quick ratio of 1.47. The firm’s fifty day moving average price is $307.09 and its 200 day moving average price is $327.45.

Molina Healthcare (NYSE:MOH – Get Rating) last released its quarterly earnings results on Wednesday, February 8th. The company reported $4.10 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.06 by $0.04. Molina Healthcare had a net margin of 2.48% and a return on equity of 36.05%. The firm had revenue of $8.22 billion for the quarter, compared to the consensus estimate of $7.87 billion. During the same quarter in the previous year, the firm posted $2.88 EPS. The firm’s quarterly revenue was up 11.0% on a year-over-year basis. On average, research analysts forecast that Molina Healthcare will post 19.75 EPS for the current fiscal year.

Insider Activity at Molina Healthcare

In other Molina Healthcare news, EVP Marc Russo sold 1,500 shares of the business’s stock in a transaction dated Monday, December 12th. The shares were sold at an average price of $351.17, for a total transaction of $526,755.00. Following the completion of the transaction, the executive vice president now directly owns 15,513 shares of the company’s stock, valued at approximately $5,447,700.21. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In other Molina Healthcare news, Director Dale B. Wolf sold 2,500 shares of the business’s stock in a transaction dated Wednesday, December 7th. The shares were sold at an average price of $339.50, for a total transaction of $848,750.00. Following the completion of the transaction, the director now directly owns 15,491 shares of the company’s stock, valued at approximately $5,259,194.50. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Marc Russo sold 1,500 shares of the business’s stock in a transaction dated Monday, December 12th. The shares were sold at an average price of $351.17, for a total transaction of $526,755.00. Following the transaction, the executive vice president now directly owns 15,513 shares of the company’s stock, valued at $5,447,700.21. The disclosure for this sale can be found here. Insiders own 1.49% of the company’s stock.

Institutional Trading of Molina Healthcare

A number of institutional investors have recently made changes to their positions in MOH. Raymond James Financial Services Advisors Inc. lifted its stake in shares of Molina Healthcare by 5.7% in the 1st quarter. Raymond James Financial Services Advisors Inc. now owns 1,651 shares of the company’s stock worth $551,000 after acquiring an additional 89 shares during the period. Allianz Asset Management GmbH lifted its stake in shares of Molina Healthcare by 496.1% in the 1st quarter. Allianz Asset Management GmbH now owns 11,534 shares of the company’s stock worth $3,848,000 after acquiring an additional 9,599 shares during the period. Prudential PLC acquired a new stake in shares of Molina Healthcare in the 1st quarter worth approximately $422,000. Cetera Investment Advisers lifted its stake in shares of Molina Healthcare by 10.1% in the 1st quarter. Cetera Investment Advisers now owns 1,296 shares of the company’s stock worth $432,000 after acquiring an additional 119 shares during the period. Finally, Mackay Shields LLC acquired a new stake in shares of Molina Healthcare in the 1st quarter worth approximately $2,814,000. 94.25% of the stock is owned by institutional investors and hedge funds.

Molina Healthcare Company Profile

(Get Rating)

Molina Healthcare, Inc engages in the provision of health care services. It operates through the following segments: Medicaid, Medicare, Marketplace, and Other. The company was founded by C. David Molina in 1980 and is headquartered in Long Beach, CA.